Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis.

Creary LE, Mallempati KC, Gangavarapu S, Caillier SJ, Oksenberg JR, Fernández-Viňa MA.

Mult Scler. 2018 Apr 1:1352458518770019. doi: 10.1177/1352458518770019. [Epub ahead of print]

PMID:
29683085
2.

Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.

Oran B, Saliba RM, Carmazzi Y, de Lima M, Rondon G, Ahmed S, Alousi A, Andersson BS, Anderlini P, Alvarez M, Bashir Q, Ciurea S, Fernandez-Vina M, Hosing C, Kebriaei P, Korbling M, Cano P, Khouri I, Marin D, Nieto Y, Olson A, Popat U, Rezvani K, Qazilbash M, Shpall EJ, Champlin RE, Cao K.

Blood. 2018 Mar 15;131(11):1248-1257. doi: 10.1182/blood-2017-07-798751. Epub 2018 Jan 31.

PMID:
29386198
3.

Multiplex family with GAD65-Abs neurologic syndromes.

Belbezier A, Joubert B, Montero-Martin G, Fernandez-Vina M, Fabien N, Rogemond V, Mignot E, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 5;5(1):e416. doi: 10.1212/NXI.0000000000000416. eCollection 2018 Jan.

4.

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity.

Spinner MA, Fernández-Viña M, Creary LE, Quinn O, Elder L, Arai S, Johnston LJ, Meyer EH, Miklos DB, Muffly LS, Negrin RS, Shizuru JA, Weng WK, Laport GG, Strober S, Lowsky R, Rezvani AR.

Blood Adv. 2017 Jul 25;1(17):1347-1357. doi: 10.1182/bloodadvances.2017007716. eCollection 2017 Jul 25.

5.

Mandenka from Senegal: Next Generation Sequencing typings reveal very high frequencies of particular HLA class II alleles and haplotypes.

Goeury T, Creary LE, Fernandez-Vina MA, Tiercy JM, Nunes JM, Sanchez-Mazas A.

HLA. 2018 Feb;91(2):148-150. doi: 10.1111/tan.13197. No abstract available.

PMID:
29280562
6.

Collection and storage of HLA NGS genotyping data for the 17th International HLA and Immunogenetics Workshop.

Chang CJ, Osoegawa K, Milius RP, Maiers M, Xiao W, Fernandez-Viňa M, Mack SJ.

Hum Immunol. 2018 Feb;79(2):77-86. doi: 10.1016/j.humimm.2017.12.004. Epub 2017 Dec 14.

PMID:
29247682
7.

Deciphering the fine nucleotide diversity of full HLA class I and class II genes in a well-documented population from sub-Saharan Africa.

Goeury T, Creary LE, Brunet L, Galan M, Pasquier M, Kervaire B, Langaney A, Tiercy JM, Fernández-Viña MA, Nunes JM, Sanchez-Mazas A.

HLA. 2018 Jan;91(1):36-51. doi: 10.1111/tan.13180.

8.

Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis.

William BM, Wang T, Haagenson MD, Fleischhauer K, Verneris M, Hsu KC, de Lima MJ, Fernandez-Viña M, Spellman SR, Lee SJ, Hill BT.

Biol Blood Marrow Transplant. 2018 Apr;24(4):827-831. doi: 10.1016/j.bbmt.2017.11.003. Epub 2017 Nov 16.

PMID:
29155319
9.

High-throughput next-generation sequencing to genotype six classical HLA loci from 96 donors in a single MiSeq run.

Ehrenberg PK, Geretz A, Sindhu RK, Vayntrub T, Fernández Viña MA, Apps R, Michael NL, Thomas R.

HLA. 2017 Nov;90(5):284-291. doi: 10.1111/tan.13133. Epub 2017 Sep 14.

PMID:
28842944
10.

HLA Amino Acid Polymorphisms and Kidney Allograft Survival.

Kamoun M, McCullough KP, Maiers M, Fernandez Vina MA, Li H, Teal V, Leichtman AB, Merion RM.

Transplantation. 2017 May;101(5):e170-e177. doi: 10.1097/TP.0000000000001670.

11.

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients.

Andersson BS, Thall PF, Valdez BC, Milton DR, Al-Atrash G, Chen J, Gulbis A, Chu D, Martinez C, Parmar S, Popat U, Nieto Y, Kebriaei P, Alousi A, de Lima M, Rondon G, Meng QH, Myers A, Kawedia J, Worth LL, Fernandez-Vina M, Madden T, Shpall EJ, Jones RB, Champlin RE.

Bone Marrow Transplant. 2017 Apr;52(4):580-587. doi: 10.1038/bmt.2016.322. Epub 2016 Dec 19.

12.

MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research Study.

Askar M, Sobecks R, Wang T, Haagenson M, Majhail N, Madbouly A, Thomas D, Zhang A, Fleischhauer K, Hsu K, Verneris M, Lee SJ, Spellman SR, Fernández-Viña M.

Biol Blood Marrow Transplant. 2017 Mar;23(3):436-444. doi: 10.1016/j.bbmt.2016.11.021. Epub 2016 Dec 14.

13.

Corrigendum to "Diversity in exon 5 of HLA-C*04:01:01G is significant in anthropological studies" [Hum. Immunol. 77 (2016) 426-428].

Dunn PPJ, Lamb G, Selwyn C, Compton J, Yang E, Maiers M, Fernandez-Vina M.

Hum Immunol. 2016 Oct;77(10):1004. doi: 10.1016/j.humimm.2016.06.008. Epub 2016 Jun 23. No abstract available.

PMID:
27345146
14.

Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research.

Lazaryan A, Wang T, Spellman SR, Wang HL, Pidala J, Nishihori T, Askar M, Olsson R, Oudshoorn M, Abdel-Azim H, Yong A, Gandhi M, Dandoy C, Savani B, Hale G, Page K, Bitan M, Reshef R, Drobyski W, Marsh SG, Schultz K, Müller CR, Fernandez-Viña MA, Verneris MR, Horowitz MM, Arora M, Weisdorf DJ, Lee SJ.

Haematologica. 2016 Oct;101(10):1267-1274. Epub 2016 May 31.

15.

Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.

Lee DA, Denman CJ, Rondon G, Woodworth G, Chen J, Fisher T, Kaur I, Fernandez-Vina M, Cao K, Ciurea S, Shpall EJ, Champlin RE.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1290-1298. doi: 10.1016/j.bbmt.2016.04.009. Epub 2016 Apr 16.

16.

Diversity in exon 5 of HLA-C(∗)04:01:01G is significant in anthropological studies.

Dunn PP, Lamb G, Selwyn C, Compton J, Yang E, Maiers M, Fernandez-Vina M.

Hum Immunol. 2016 May;77(5):426-8. doi: 10.1016/j.humimm.2016.03.007. Epub 2016 Mar 24. Erratum in: Hum Immunol. 2016 Oct;77(10):1004.

PMID:
27018403
17.

High levels of anti-tuberculin (IgG) antibodies correlate with the blocking of T-cell proliferation in individuals with high exposure to Mycobacterium tuberculosis.

Feris EJ, Encinales L, Awad C, Stern JNH, Tabansky I, Jiménez-Alvarez L, Ramírez-Martínez G, Cruz-Lagunas A, Bobadilla K, Márquez E, Granados-Montiel J, Rodriguez-Reyna TS, Fernandez-Vina M, Granados J, Zuñiga J, Yunis EJ.

Int J Infect Dis. 2016 Feb;43:21-24. doi: 10.1016/j.ijid.2015.12.004. Epub 2015 Dec 11.

18.

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.

Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Viña M, Hartzman RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, Mueller CR, Perales MA, Setterholm M, Woolfrey AE, Yu N, Eapen M.

Blood. 2016 Jan 14;127(2):260-7. doi: 10.1182/blood-2015-08-663823. Epub 2015 Nov 2.

19.

Minimum information for reporting next generation sequence genotyping (MIRING): Guidelines for reporting HLA and KIR genotyping via next generation sequencing.

Mack SJ, Milius RP, Gifford BD, Sauter J, Hofmann J, Osoegawa K, Robinson J, Groeneweg M, Turenchalk GS, Adai A, Holcomb C, Rozemuller EH, Penning MT, Heuer ML, Wang C, Salit ML, Schmidt AH, Parham PR, Müller C, Hague T, Fischer G, Fernandez-Viňa M, Hollenbach JA, Norman PJ, Maiers M.

Hum Immunol. 2015 Dec;76(12):954-62. doi: 10.1016/j.humimm.2015.09.011. Epub 2015 Sep 25.

20.

Better allele-level matching improves transplant-related mortality after double cord blood transplantation.

Oran B, Cao K, Saliba RM, Rezvani K, de Lima M, Ahmed S, Hosing CM, Popat UR, Carmazzi Y, Kebriaei P, Nieto Y, Rondon G, Willis D, Shah N, Parmar S, Olson A, Moore B, Marin D, Mehta R, Fernández-Viña M, Champlin RE, Shpall EJ.

Haematologica. 2015 Oct;100(10):1361-70. doi: 10.3324/haematol.2015.127787. Epub 2015 Aug 6.

21.

Limited Variation in BK Virus T-Cell Epitopes Revealed by Next-Generation Sequencing.

Sahoo MK, Tan SK, Chen SF, Kapusinszky B, Concepcion KR, Kjelson L, Mallempati K, Farina HM, Fernández-Viña M, Tyan D, Grimm PC, Anderson MW, Concepcion W, Pinsky BA.

J Clin Microbiol. 2015 Oct;53(10):3226-33. doi: 10.1128/JCM.01385-15. Epub 2015 Jul 22.

22.

HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.

Verneris MR, Lee SJ, Ahn KW, Wang HL, Battiwalla M, Inamoto Y, Fernandez-Vina MA, Gajewski J, Pidala J, Munker R, Aljurf M, Saber W, Spellman S, Koreth J.

Biol Blood Marrow Transplant. 2015 Oct;21(10):1783-9. doi: 10.1016/j.bbmt.2015.05.028. Epub 2015 Jun 6.

23.

Very high resolution single pass HLA genotyping using amplicon sequencing on the 454 next generation DNA sequencers: Comparison with Sanger sequencing.

Yamamoto F, Höglund B, Fernandez-Vina M, Tyan D, Rastrou M, Williams T, Moonsamy P, Goodridge D, Anderson M, Erlich HA, Holcomb CL.

Hum Immunol. 2015 Dec;76(12):910-6. doi: 10.1016/j.humimm.2015.05.002. Epub 2015 May 30.

PMID:
26037172
24.

Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.

Ciurea SO, Thall PF, Milton DR, Barnes TH, Kongtim P, Carmazzi Y, López AA, Yap DY, Popat U, Rondon G, Lichtiger B, Aung F, Afshar-Kharghan V, Ma Q, Fernández-Viña M, Champlin RE, Cao K.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1392-8. doi: 10.1016/j.bbmt.2015.05.001. Epub 2015 May 15.

25.

Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

Sobecks RM, Wang T, Askar M, Gallagher MM, Haagenson M, Spellman S, Fernandez-Vina M, Malmberg KJ, Müller C, Battiwalla M, Gajewski J, Verneris MR, Ringdén O, Marino S, Davies S, Dehn J, Bornhäuser M, Inamoto Y, Woolfrey A, Shaw P, Pollack M, Weisdorf D, Milller J, Hurley C, Lee SJ, Hsu K.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1589-96. doi: 10.1016/j.bbmt.2015.05.002. Epub 2015 May 8.

26.

Comparison of risk-based hepatitis C screening and the true seroprevalence in an urban prison system.

Kuncio DE, Newbern EC, Fernandez-Viña MH, Herdman B, Johnson CC, Viner KM.

J Urban Health. 2015 Apr;92(2):379-86. doi: 10.1007/s11524-015-9945-4.

27.

Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?

Hamdi A, Cao K, Poon LM, Aung F, Kornblau S, Fernandez Vina MA, Champlin RE, Ciurea SO.

Bone Marrow Transplant. 2015 Mar;50(3):411-3. doi: 10.1038/bmt.2014.285. Epub 2015 Jan 26.

28.

HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy.

Ollila HM, Ravel JM, Han F, Faraco J, Lin L, Zheng X, Plazzi G, Dauvilliers Y, Pizza F, Hong SC, Jennum P, Knudsen S, Kornum BR, Dong XS, Yan H, Hong H, Coquillard C, Mahlios J, Jolanki O, Einen M, Arnulf I, Högl B, Frauscher B, Crowe C, Partinen M, Huang YS, Bourgin P, Vaarala O, Désautels A, Montplaisir J, Mack SJ, Mindrinos M, Fernandez-Vina M, Mignot E.

Am J Hum Genet. 2015 Jan 8;96(1):136-46. doi: 10.1016/j.ajhg.2014.12.010. Erratum in: Am J Hum Genet. 2015 May 7;96(5):852. Lavault, Sophie [removed]; Arnulf, Isabelle [added].

29.

HLA allotype expressivity in transplantation.

Fernández-Viña MA.

Blood. 2014 Dec 18;124(26):3839-40. doi: 10.1182/blood-2014-10-607853. No abstract available.

30.
31.

Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).

Howard CA, Fernandez-Vina MA, Appelbaum FR, Confer DL, Devine SM, Horowitz MM, Mendizabal A, Laport GG, Pasquini MC, Spellman SR.

Biol Blood Marrow Transplant. 2015 Jan;21(1):4-7. doi: 10.1016/j.bbmt.2014.09.017. Epub 2014 Sep 30.

32.

HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency.

Han F, Lin L, Schormair B, Pizza F, Plazzi G, Ollila HM, Nevsimalova S, Jennum P, Knudsen S, Winkelmann J, Coquillard C, Babrzadeh F, Strom TM, Wang C, Mindrinos M, Fernandez Vina M, Mignot E.

Sleep. 2014 Oct 1;37(10):1601-8. doi: 10.5665/sleep.4066.

33.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

Pidala J, Lee SJ, Ahn KW, Spellman S, Wang HL, Aljurf M, Askar M, Dehn J, Fernandez Viña M, Gratwohl A, Gupta V, Hanna R, Horowitz MM, Hurley CK, Inamoto Y, Kassim AA, Nishihori T, Mueller C, Oudshoorn M, Petersdorf EW, Prasad V, Robinson J, Saber W, Schultz KR, Shaw B, Storek J, Wood WA, Woolfrey AE, Anasetti C.

Blood. 2014 Oct 16;124(16):2596-606. doi: 10.1182/blood-2014-05-576041. Epub 2014 Aug 26.

34.

Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders.

Canellas F, Lin L, Julià MR, Clemente A, Vives-Bauza C, Ollila HM, Hong SC, Arboleya SM, Einen MA, Faraco J, Fernandez-Vina M, Mignot E.

J Clin Sleep Med. 2014 Sep 15;10(9):1011-8. doi: 10.5664/jcsm.4040.

35.

Validation of statistical imputation of allele-level multilocus phased genotypes from ambiguous HLA assignments.

Madbouly A, Gragert L, Freeman J, Leahy N, Gourraud PA, Hollenbach JA, Kamoun M, Fernandez-Vina M, Maiers M.

Tissue Antigens. 2014 Sep;84(3):285-92. doi: 10.1111/tan.12390. Epub 2014 Jul 11.

PMID:
25040134
36.

Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.

Fleischhauer K, Fernandez-Viña MA, Wang T, Haagenson M, Battiwalla M, Baxter-Lowe LA, Ciceri F, Dehn J, Gajewski J, Hale GA, Heemskerk MB, Marino SR, McCarthy PL, Miklos D, Oudshoorn M, Pollack MS, Reddy V, Senitzer D, Shaw BE, Waller EK, Lee SJ, Spellman SR.

Bone Marrow Transplant. 2014 Sep;49(9):1176-83. doi: 10.1038/bmt.2014.122. Epub 2014 Jun 23.

37.

Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.

Sengsayadeth S, Wang T, Lee SJ, Haagenson MD, Spellman S, Fernandez Viña MA, Muller CR, Verneris MR, Savani BN, Jagasia M.

Biol Blood Marrow Transplant. 2014 Jun;20(6):900-3. doi: 10.1016/j.bbmt.2014.03.005. Epub 2014 Mar 14.

38.

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.

Fernandez-Viña MA, Wang T, Lee SJ, Haagenson M, Aljurf M, Askar M, Battiwalla M, Baxter-Lowe LA, Gajewski J, Jakubowski AA, Marino S, Oudshoorn M, Marsh SG, Petersdorf EW, Schultz K, Turner EV, Waller EK, Woolfrey A, Umejiego J, Spellman SR, Setterholm M.

Blood. 2014 Feb 20;123(8):1270-8. doi: 10.1182/blood-2013-10-532671. Epub 2014 Jan 9.

39.

Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.

Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, Arcese W, Barker JN, Baxter-Lowe LA, Brown M, Fernandez-Vina MA, Freeman J, He W, Iori AP, Horowitz MM, Locatelli F, Marino S, Maiers M, Michel G, Sanz GF, Gluckman E, Rocha V; Center for International Blood and Marrow Transplant Research, Netcord, Eurocord, and the European Group for Blood and Marrow Transplantation.

Blood. 2014 Jan 2;123(1):133-40. doi: 10.1182/blood-2013-05-506253. Epub 2013 Oct 18.

40.

HLA class I and class II conserved extended haplotypes and their fragments or blocks in Mexicans: implications for the study of genetic diversity in admixed populations.

Zúñiga J, Yu N, Barquera R, Alosco S, Ohashi M, Lebedeva T, Acuña-Alonzo V, Yunis M, Granados-Montiel J, Cruz-Lagunas A, Vargas-Alarcón G, Rodríguez-Reyna TS, Fernandez-Viña M, Granados J, Yunis EJ.

PLoS One. 2013 Sep 23;8(9):e74442. doi: 10.1371/journal.pone.0074442. eCollection 2013.

41.

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.

Pidala J, Wang T, Haagenson M, Spellman SR, Askar M, Battiwalla M, Baxter-Lowe LA, Bitan M, Fernandez-Viña M, Gandhi M, Jakubowski AA, Maiers M, Marino SR, Marsh SG, Oudshoorn M, Palmer J, Prasad VK, Reddy V, Ringden O, Saber W, Santarone S, Schultz KR, Setterholm M, Trachtenberg E, Turner EV, Woolfrey AE, Lee SJ, Anasetti C.

Blood. 2013 Nov 21;122(22):3651-8. doi: 10.1182/blood-2013-05-501510. Epub 2013 Aug 27.

42.

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

Fernández-Viña MA, Klein JP, Haagenson M, Spellman SR, Anasetti C, Noreen H, Baxter-Lowe LA, Cano P, Flomenberg N, Confer DL, Horowitz MM, Oudshoorn M, Petersdorf EW, Setterholm M, Champlin R, Lee SJ, de Lima M.

Blood. 2013 May 30;121(22):4603-10. doi: 10.1182/blood-2013-02-481945. Epub 2013 Apr 17.

43.

Common and well-documented HLA alleles: 2012 update to the CWD catalogue.

Mack SJ, Cano P, Hollenbach JA, He J, Hurley CK, Middleton D, Moraes ME, Pereira SE, Kempenich JH, Reed EF, Setterholm M, Smith AG, Tilanus MG, Torres M, Varney MD, Voorter CE, Fischer GF, Fleischhauer K, Goodridge D, Klitz W, Little AM, Maiers M, Marsh SG, Müller CR, Noreen H, Rozemuller EH, Sanchez-Mazas A, Senitzer D, Trachtenberg E, Fernandez-Vina M.

Tissue Antigens. 2013 Apr;81(4):194-203. doi: 10.1111/tan.12093.

44.

Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation.

Dobbelstein C, Ahn KW, Haagenson M, Hale GA, van Rood JJ, Miklos D, Waller EK, Spellman SR, Fernandez-Vina M, Ganser A, Aljurf M, Bornhaeuser M, Gupta V, Marino SR, Pollack MS, Reddy V, Eder M, Lee SJ.

Biol Blood Marrow Transplant. 2013 May;19(5):741-5. doi: 10.1016/j.bbmt.2013.01.020. Epub 2013 Feb 1.

45.

16(th) IHIW: global distribution of extended HLA haplotypes.

Askar M, Daghstani J, Thomas D, Leahy N, Dunn P, Claas F, Doran S, Saji H, Kanangat S, Karoichane M, Tambur A, Monos D, El-Khalifa M, Turner V, Kamoun M, Mustafa M, Ramon D, Gandhi M, Vernaza A, Gorodezky C, Wagenknecht D, Gautreaux M, Hajeer A, Kashi Z, Fernandez-Vina M.

Int J Immunogenet. 2013 Feb;40(1):31-8. doi: 10.1111/iji.12029.

46.

16(th) IHIW: extending the number of resources and bioinformatics analysis for the investigation of HLA rare alleles.

Gonzalez-Galarza FF, Mack SJ, Hollenbach J, Fernandez-Vina M, Setterholm M, Kempenich J, Marsh SG, Jones AR, Middleton D; HLA Rare Allele Consortium.

Int J Immunogenet. 2013 Feb;40(1):60-5. doi: 10.1111/iji.12030. Epub 2012 Dec 1.

PMID:
23198982
47.

New approaches in alternative donor transplantation.

Fernandez Vina M, Heslop HE, Barker JN.

Biol Blood Marrow Transplant. 2013 Jan;19(1 Suppl):S91-6. doi: 10.1016/j.bbmt.2012.10.027. Epub 2012 Oct 27. Review. No abstract available.

48.

HLA factors in transplantation for nonmalignant hematologic disorders.

Fernandez-Viña MA.

Blood. 2012 Oct 4;120(14):2781-2. doi: 10.1182/blood-2012-08-446567.

49.

HLA population genetics: a Lebanese population.

Cano P, Testi M, Andreani M, Khoriaty E, Bou Monsef J, Galluccio T, Troiano M, Fernandez-Vina M, Inati A.

Tissue Antigens. 2012 Oct;80(4):341-55. doi: 10.1111/j.1399-0039.2012.01936.x.

PMID:
22994155
50.

Cytokine gene polymorphisms affect reactivation of cytomegalovirus in patients with cancer.

Cano P, Han FS, Wang HL, Fernandez-Vina M, Han XY.

Cytokine. 2012 Nov;60(2):417-22. doi: 10.1016/j.cyto.2012.07.018. Epub 2012 Aug 13.

PMID:
22898395

Supplemental Content

Loading ...
Support Center